Sang Guowei: Strive to independently create 30 innovative drugs during the "Twelfth Five-Year Plan"

Sang Guowei, vice chairman of the Standing Committee of the Eleventh National People's Congress, said at the fourth China (Taizhou) International Pharmaceutical exposition that the goal of the "12th Five Year Plan" major new drug development project is to independently create 30 innovative drugs, transform about 200 large drug varieties, and focus on breaking through 20-30 key technologies Among them, there are 70 chemical drug focused topics, mainly focused on bacterial resistant pathogenic infection, viral infectious diseases, cardiovascular and cerebrovascular diseases and malignant tumors In the aspect of traditional Chinese medicine, the second development of large varieties of traditional Chinese medicine, the internationalization of new traditional Chinese medicine and the safety evaluation of traditional Chinese medicine injection will become the research focus In the field of Biopharmaceutics, sang Guowei suggested supporting stem cell therapy and research and development of recombinant coagulation factors Sang Guowei also pointed out that during the 11th Five Year Plan period, 94% of the subjects passed the acceptance, of which 174 were excellent subjects and were intended to be candidates for rolling support; 27 subjects failed the acceptance; 41 subjects returned supplementary materials.